Cancer Genetics Reports Third Quarter 2019 Financial Results and Provides Strategic Business Update
November 20, 2019 08:00 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J., Nov. 20, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced strategic,...
Cancer Genetics, Inc. Announces Strategic Transactions
October 24, 2019 16:15 ET
|
Cancer Genetics, Inc.
Note Payment Received from Interpace Diagnostics Group, Inc. Settlement Agreement with NovellusDx Restructured Note Agreement with Unsecured Lender M&A Advisory Agreement with H.C....
Cancer Genetics Announces 1-for-30 Reverse Stock Split
October 24, 2019 08:30 ET
|
Cancer Genetics, Inc.
RUTHERFORD, N.J, Oct. 24, 2019 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX), a leader in drug discovery and preclinical oncology and immuno-oncology services, today announced that it...